Application 020886

Type
NDA
Sponsor
CONCORDIA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001PANRETINALITRETINOINGEL;TOPICALEQ 0.1% BASEYesYes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N020886-001PANRETINALITRETINOINEQ 0.1% BASEGEL / TOPICALRLD, RS1999-02-02

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02N020886-001PANRETINEQ 0.1% BASEGEL / TOPICALRLD, RS1999-02-02011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020886-001PANRETINEQ 0.1% BASEGEL / TOPICALRLD, RS1999-02-0231067a03dcf5…
2025-08-23 18:47 UTC2025-08N020886-001PANRETINEQ 0.1% BASEGEL / TOPICALRLD, RS1999-02-026a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020886-001PANRETINEQ 0.1% BASEGEL / TOPICALRLD, RS1999-02-02fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020886-001PANRETINEQ 0.1% BASEGEL / TOPICALRLD, RS1999-02-02b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020886-001PANRETINEQ 0.1% BASEGEL / TOPICALRLD, RS1999-02-0203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020886-001PANRETINEQ 0.1% BASEGEL / TOPICALRLD, RS1999-02-022680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020886-001PANRETINEQ 0.1% BASEGEL / TOPICALRLD, RS1999-02-025bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020886-001PANRETINEQ 0.1% BASEGEL / TOPICALRLD, RS1999-02-02d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N020886-001PANRETINEQ 0.1% BASEGEL / TOPICALRLD, RS1999-02-02d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N020886-001PANRETINEQ 0.1% BASEGEL / TOPICALRLD, RS1999-02-0279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N020886-001PANRETINEQ 0.1% BASEGEL / TOPICALRLD, RS1999-02-02301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N020886-001PANRETINEQ 0.1% BASEGEL / TOPICALRLD, RS1999-02-021e350fbaab3a…
2024-05-31 18:47 UTC2024-05N020886-001PANRETINEQ 0.1% BASEGEL / TOPICALRLD, RS1999-02-028072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N020886-001PANRETINEQ 0.1% BASEGEL / TOPICALRLD, RS1999-02-025c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N020886-001PANRETINEQ 0.1% BASEGEL / TOPICALRLD, RS1999-02-025d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N020886-001PANRETINEQ 0.1% BASEGEL / TOPICALRLD, RS1999-02-024b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N020886-001PANRETINEQ 0.1% BASEGEL / TOPICALRLD, RS1999-02-0274a2ff9319b5…
2022-03-09 01:35 UTC2022-03N020886-001PANRETINEQ 0.1% BASEGEL / TOPICALRLD, RS1999-02-02bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N020886-001PANRETINEQ 0.1% BASEGEL / TOPICALRLD, RS1999-02-02782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N020886-001PANRETINEQ 0.1% BASEGEL / TOPICALRLD, RS1999-02-0287673890dc5c…
2021-03-12 10:30 UTC2021-03N020886-001PANRETINEQ 0.1% BASEGEL / TOPICALRLD, RS1999-02-025aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N020886-001PANRETINEQ 0.1% BASEGEL / TOPICALRLD, RS1999-02-028869cabd3fbd…
2020-11-12 02:37 UTC2020-11N020886-001PANRETINEQ 0.1% BASEGEL / TOPICALRLD, RS1999-02-02c0c555d07b60…
2019-12-14 00:12 UTC2019-12N020886-001PANRETINEQ 0.1% BASEGEL / TOPICALRLD, RS1999-02-023f01610625f2…
2019-09-15 20:21 UTC2019-09N020886-001PANRETINEQ 0.1% BASEGEL / TOPICALRLD, RS1999-02-02b00525d2431f…
2019-07-19 19:46 UTC2019-07N020886-001PANRETINEQ 0.1% BASEGEL / TOPICALRLD, RS1999-02-02ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N020886-001PANRETINEQ 0.1% BASEGEL / TOPICALRLD, RS1999-02-026a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N020886-001PANRETINEQ 0.1% BASEGEL / TOPICALRLD, RS1999-02-021c564ffb4f44…
2023-12-20 04:57 UTC2023-12N020886-001PANRETINEQ 0.1% BASEGEL / TOPICALRLD, RS1999-02-02ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N020886-001PANRETINEQ 0.1% BASEGEL / TOPICALRLD, RS1999-02-02a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N020886-001PANRETINEQ 0.1% BASEGEL / TOPICALRLD, RS1999-02-029b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N020886-001PANRETINEQ 0.1% BASEGEL / TOPICALRLD, RS1999-02-02a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N020886-001PANRETINEQ 0.1% BASEGEL / TOPICALRLD, RS1999-02-023f0d92c62455…
2023-05-13 08:27 UTC2023-05N020886-001PANRETINEQ 0.1% BASEGEL / TOPICALRLD, RS1999-02-02053a50430f4f…
2023-01-26 05:58 UTC2023-01N020886-001PANRETINEQ 0.1% BASEGEL / TOPICALRLD, RS1999-02-023bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N020886-001PANRETINEQ 0.1% BASEGEL / TOPICALRLD, RS1999-02-023a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N020886-001PANRETINEQ 0.1% BASEGEL / TOPICALRLD, RS1999-02-02f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N020886-001PANRETINEQ 0.1% BASEGEL / TOPICALRLD, RS1999-02-02e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N020886-001PANRETINEQ 0.1% BASEGEL / TOPICALRLD, RS1999-02-02cb3db0bc1861…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PANRETINALITRETINOINAdvanz Pharma (US) Corp.49c16717-7d86-4257-80c9-baa1417e55552025-11-25Warnings, Adverse reactionsExact identifier
application applno (NDA): 020886
application number: NDA020886
ndc (product): 59212-601

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 5 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
59212-601PANRETINalitretinoinConcordia Pharmaceuticals Inc.NDACurrent
59212-601PANRETINalitretinoinConcordia Pharmaceuticals Inc.NDACurrent
59212-601PANRETINalitretinoinConcordia Pharmaceuticals Inc.NDACurrent
62856-601PanretinAlitretinoinEisai Inc.NDACurrent
62856-601PanretinAlitretinoinEisai Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
84198SUPPL 2025-11-18
84197SUPPL 2025-11-18
84194SUPPL 2025-11-18
21043ORIG1999-02-02
13670ORIG1999-02-02
3655ORIG1999-02-02